Begriffe, Krankheiten, Einrichtungen u.v.m., verknüpft mit dem zuständigen Bereich.
Im Menüpunkt "Übersicht" sind Einrichtungen unter verschiedenen Gesichtspunkten gruppiert: Kliniken, Abteilungen, Institute, Zentrale Einrichtungen und ähnliches.
Dr. med. Patrick Stoll |
zurück > |
Publikationen |
Originalarbeiten
Stoll P, Schwer CI, Goebel U, Buerkle H, Hoetzel A, Schmidt R.
Hepatic steatosis prevents heme oxygenase-1 induction by isoflurane in the rat liver.
World J Gastroenterol 2011; 17(37): 4184-4190
Schwer CI, Stoll P, Goebel U, Buerkle H, Hoetzel A, Schmidt R.
Effects of hydrogen sulfide on rat pancreatic stellate cells.
Pancreas 2012; 41(1): 74-83
Schallner N, Schwemmers S, Schwer CI, Froehlich C, Stoll P, Humar M, Pahl HL, Hoetzel A, Loop T, Goebel U. p38β-regulated induction of the heat shock response by carbon monoxide releasing molecule CORM-2 mediates cytoprotection in lung cells in vitro.
Eur J Pharmacol. 2011; 670(1): 58-66.
Schwer CI*, Stoll P*, Pietsch U, Stein P, Laqua J, Goebel U, Hoetzel A, Schmidt R.
Upregulation of heme oxygenase-1 by sevoflurane is not dependent on kupffer cells and associates with ERK1/2 and AP-1 in the rat liver.
Int J Biochem Cell Biol 2010; 42(11): 1876-1883 * geteilte Erstautorenschaft
Schwer CI, Mutschler M, Goebel U, Stoll P, Humar M, Hoetzel A, Schmidt R.
Carbon monoxide releasing molecule-2 inhibits pancreatic stellate cell proliferation by activating p38 MAPK/HO-1 signaling.
Mol Pharmacol 2010; 77(4): 660-669
Schwer CI, Guerrero AM, Humar M, Roesslein M, Goebel U, Stoll P, Geiger KK, Pannen BH, Hoetzel A, Schmidt R.
Heme oxygenase-1 inhibits the proliferation of pancreatic stellate cells by repression of the ERK1/2 pathway.
J Pharmacol Exp Ther 2008; 327(3): 863-871
Stoll P, Bassler N, Hagemeyer CE, Eisenhardt SU, Chih CY, Schmidt R, Schwarz M, Ahrens I, Katagiri Y, Pannen B, Bode C, Peter K.
Targeting ligand-induced binding sites on GPIIb/IIIa via single-chain antibody allows effective anticoagulation without bleeding time prolongation.
Arterioscler Thromb Vasc Biol 2007; 27(5): 1206-12
Schwarz M, Meade G, Stoll P, Ylanne J, Bassler N, Chen YC, Hagemeyer CE, Ahrens I, Moran N, Kenny D, Fitzgerald D, Bode C, Peter K.
Conformation-specific blockade of the integrin GPIIb/IIIa: a novel antiplatelet strategy that selectively targets activated platelets.
Circ Res. 2006 Jul 7; 99(1): 25-33.
Abstracts, Kongressbeiträge
Stoll P, Schwer CI, Stein P, Pietsch U, Laqua J, Schmidt R.
Up-regulation of heme oxygenase-1 by sevoflurane is not dependent on kupffer cells and associates with ERK1/2 and AP-1 activation in the rat liver.
IARS 2010 Annual Meeting, Honolulu, Hawaii, USA, 2010
Schwer CI, Stoll P, Schmidt R.
Carbon monoxide releasing molecule-2 inhibits rat pancreatic stellate cell proliferation by up-regulation of heme oxygenase-1.
IARS 2010 Annual Meeting, Honolulu, Hawaii, USA, 2010
Schwer CI, Stoll P, Goebel U, Hoetzel A, Schmidt R.
Das Kohlenmonoxid-freisetzende Molekül CORM-2 hemmt die Proliferation primärer pankreatischer Sternzellen durch eine p38-abhängige Induktion der Hämoxygenase-1.
HAI 2009, Der Hauptstadtkongress der DGAI, Berlin, 2009
Schwer CI, Stoll P, Laqua J, Pietsch U, Hoetzel A, Schmidt R.
Die Sevofluran vermittelte HO-1 Induktion in Hepatozyten ist nicht Kupfferzell-abhängig und geht mit einer Aktivierung von ERK1/2 und AP-1 einher.
HAI 2009, Der Hauptstadtkongress der DGAI, Berlin, 2009
Schwer CI, Stoll P, Goebel U, Hoetzel A, Schmidt R.
Carbon monoxide releasing molecule-2 blocks pancreatic stellate cell growth by a p38 MAPK dependent mechanism.
Heme oxygenases in Biology and Medicine 2009. The 6th International Congress, Miami, USA, 2009
Stoll P, Schwer CI, Hoetzel A, Schmidt R.
Sevoflurane mediated HO-1 induction in hepatocytes is associated with ERK1/2 and AP-1 activation and does not depend on Kupffer cells.
Heme oxygenases in Biology and Medicine 2009. The 6th International Congress, Miami, USA, 2009
Schwer CI, Guerrero AM, Goebel U, Stoll P, Geiger K, Hoetzel A, Schmidt R.
Das Enzym Hämoxygenase-1 hemmt die Proliferation primärer pankreatischer Sternzellen über eine ERK1/2-abhängigen Mechanismus.
HAI 2008, Der Hauptstadtkongress der DGAI, Berlin, 2008
Stoll P, Bassler N, Hagemeyer CE, Schmidt R, Chih CY, Katagiri Y, Bode C, Peter K.
Ligand-binding induced epitopes on GPIIb/IIIa allow highly efficient clot-targeted anticoagulation without bleeding time prolongation: A biotechnological approach based on the single-chain antibody technology.
AHA Scientific Sessions 2006, Chicago, USA
Circulation 2006; 114 (18): 105
Stoll P, Bassler N, Hagemeyer CE, Schmidt R, Schwarz M, Ahrens I, Bode C, Peter K.
Targeted direct FXa inhibitor composed of TAP and a single-chain antibody against a LIBS epitope on GPIIb/IIIa provides effective anticoagulation without bleeding time prolongation.
72. Jahrestagung der Deutschen Gesellschaft für Kardiologie- Herz- und Kreislaufforschung e.V., Mannheim, 2006
Clin Res Cardiol 2006; 95 (Suppl 5): V1566
Hagemeyer CE, Stoll P, Bassler N, Peter K.
A novel targeted direct fXa inhibitor fusion protein composed of TAP and a single-chain antibody directed against a LIBS Epitope on GPII/IIIa provides effective anticoagulation without bleeding time prolongation
Australian National Heart Foundation Conference 2006, Sydney, Australia
Stoll P, Bassler N, Hagemeyer CE, Schmidt R, Ahrens I, Schwarz M, Bode C, Peter K.
Targeting of the direct FXa inhibitor TAP via the fusion of a single-chain antibody directed against a LIBS epitope on GPIIb/IIIa provides effective anticoagulation without bleeding time prolongation. Congress of the International Society on Thrombosis and Haemostasis, Sydney, Australia, 2005.
J Thromb Haemost 2005; 3 (Suppl 1): OR338
Hagemeyer CE, Stoll P, Bassler N, Peter K.
Targeted direct fXa inhibitor composed of TAP and a single-chain antibody directed against a LIBS Epitope on GPII/IIIa provides effective anticoagulation without bleeding time prolongation
Proceedings of the Australian Society of Clinical and Experimental Pharmacologists and Toxicologists 2005, Sydney, Australia
zurück > |
